These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 5316651)

  • 21. [Treatment of angiodystrophic skin diseases with ginkgo-biloba].
    Nazzaro P; Di Carlo A
    Minerva Med; 1973 Nov; 64(79 Suppl):4198-200. PubMed ID: 4592297
    [No Abstract]   [Full Text] [Related]  

  • 22. [A new peripheral vasodilator agent. Personal experience with naphtidrofuryl].
    Romero RL; Vives C; Pastor C; Valdivia Velarde H; Basso G; Bordone JC
    Prensa Med Argent; 1970 May; 57(11):537-42. PubMed ID: 5454084
    [No Abstract]   [Full Text] [Related]  

  • 23. [Stugeron in treatment of headache of vascular origin].
    Domzal T
    Wiad Lek; 1972 Jul; 25(14):1295-6. PubMed ID: 5054660
    [No Abstract]   [Full Text] [Related]  

  • 24. [Experience with the vasodilator agent spasmocyclone].
    Priessnitz O
    Med Welt; 1966 Jun; 26():1433-6. PubMed ID: 5962718
    [No Abstract]   [Full Text] [Related]  

  • 25. [On the therapy of peripheral circulatory disorders with the new angioactivator Tebonin of plant origin].
    Krammer F
    Med Welt; 1966 Jul; 28():1524-8. PubMed ID: 5984513
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experience with Complamin in peripheral circulation disorders].
    Wittenburg H
    Med Monatsschr; 1969 Dec; 23(12):558-61. PubMed ID: 5387170
    [No Abstract]   [Full Text] [Related]  

  • 27. [Use of a compound of Euclidan and synthetic local anesthetics, by endarterial injection, in the treatment of 45 cases of vascular disease. Clinical results].
    Reboul H; Vergoz L
    Clinique (Paris); 1965 Jun; 60(608):449-60. PubMed ID: 5845021
    [No Abstract]   [Full Text] [Related]  

  • 28. [On the therapy of cerebral and peripheral circulatory disorders in general practice].
    Risse S
    Med Welt; 1967 Jul; 28():1659-62. PubMed ID: 5612140
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effects of flunarizine on chronic cerebrovascular insufficiency: experience of a geriatric department].
    Ronchini P; D'Ambrosio E; Anesi E; Pellicioni P
    G Clin Med; 1982 Feb; 63(2):131-9. PubMed ID: 7106462
    [No Abstract]   [Full Text] [Related]  

  • 30. [On the use of cinnarizine dihydrochloride in the treatment of arteriosclerotic cerebropathy].
    Di Lorenzo S; Costagliola A; Lampasi D; Alfano S
    Minerva Cardioangiol; 1974 Dec; 22(12):867-70. PubMed ID: 4459730
    [No Abstract]   [Full Text] [Related]  

  • 31. [Use of citrate nicamétate at high doses in cardiovascular surgery].
    Stankowiak C; Vandecasteele J; Soots G
    Lille Med; 1973 Nov; 18(9):1039-42. PubMed ID: 4211730
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapy of peripheral circulation disorders. Double-blind study on the effect of fludilat].
    König FK
    Med Welt; 1972 May; 23(20):763-8. PubMed ID: 5037194
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical trial of a delayed-action preparation of beta pyridyl-carbinol in vascular pathology].
    Warembourg H; Thery C
    Lille Med; 1970 Apr; 15(4 Suppl 3):599-602. PubMed ID: 5424406
    [No Abstract]   [Full Text] [Related]  

  • 34. [Therapeutic experiences with an adenosine-theophylline Sodium-nicotinate combination in peripheral circulation disorders].
    Weber G; Vogel A
    Dermatol Wochenschr; 1967 Nov; 153(46):1278-82. PubMed ID: 5588908
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapeutic effects of slow acting nicotinyl alcohol in vascular diseases].
    Chiti E
    Clin Ter; 1965 Oct; 35(1):38-53. PubMed ID: 5860388
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of circulatory insufficiency with buflomedil chlorhydrate in chronic hemodialysis patients].
    Montemurro NE; Damiano M
    Clin Ter; 1986 Mar; 116(6):485-9. PubMed ID: 3720235
    [No Abstract]   [Full Text] [Related]  

  • 37. The action of tetranicotinoylfructose in peripheral vascular disease.
    Andrews G; Judge TG; Walkey F
    Practitioner; 1973 Jul; 211(261):83-5. PubMed ID: 4580277
    [No Abstract]   [Full Text] [Related]  

  • 38. [Critical observations on vasodilator agents in peripheral vascular diseases and cerebrovascular disorders].
    Hamming JJ; van der Drift JH
    Ned Tijdschr Geneeskd; 1968 Mar; 112(13):611-4. PubMed ID: 5664995
    [No Abstract]   [Full Text] [Related]  

  • 39. [Vasodilators. Clinical effect in peripheral vascular disorders. A survey of the literature].
    Hallén LG
    Lakartidningen; 1965 Sep; 62(39):3149-52. PubMed ID: 5330352
    [No Abstract]   [Full Text] [Related]  

  • 40. The influence of vasodilator drugs on walking, in chronic occlusion of the leg arteries.
    Schlüssel H
    Angiologica; 1966; 3(6):370-6. PubMed ID: 5958239
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.